Skip to main content
. 2022 Mar 24;13:861670. doi: 10.3389/fimmu.2022.861670

Figure 10.

Figure 10

Adoptive transfer of Jurkat Tregs improves survival of VISTA-/- mice post CLP. Blockade of VISTA in Jurkat Tregs in vitro reduces viability and cytokine production. (A) 14-day survival following adoptive transfer and CLP [VISTA-/-(HBSS alone): n = 11, VISTA-/-(HBSS+ Jurkat Tregs): n = 10]. (B) Alamar Blue viability assay of Jurkat Tregs following treatment with Ig control or 13F3. (C–I) Supernatant cytokine concentration of Jurkat Tregs following treatment with plasma from septic mouse (stimulated) or plasma and 13F3 (stim. + 13F3). Summary graphs show mean ± SEM; not significant ns; significance #p = 0.05; *p < 0.05; **p < 0.01.